0001209191-23-049510.txt : 20230914
0001209191-23-049510.hdr.sgml : 20230914
20230914193247
ACCESSION NUMBER: 0001209191-23-049510
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230914
FILED AS OF DATE: 20230914
DATE AS OF CHANGE: 20230914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: You Angie
CENTRAL INDEX KEY: 0001647664
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41799
FILM NUMBER: 231256273
MAIL ADDRESS:
STREET 1: C/O AMUNIX PHARMACEUTICALS, INC.
STREET 2: 2 TOWER PLACE, #1100
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RayzeBio, Inc.
CENTRAL INDEX KEY: 0001825367
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5505 MOREHOUSE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (619) 937-2754
MAIL ADDRESS:
STREET 1: 5505 MOREHOUSE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-09-14
0
0001825367
RayzeBio, Inc.
RYZB
0001647664
You Angie
C/O RAYZEBIO, INC.
5505 MOREHOUSE DRIVE, SUITE 300
SAN DIEGO
CA
92121
1
0
0
0
Employee Stock Option (Right to Buy)
3.24
2032-03-21
Common Stock
73731
D
Employee Stock Option (Right to Buy)
3.24
2032-11-30
Common Stock
40848
D
The option is subject to an early exercise provision and is immediately exercisable. Vesting is monthly over a 36-month period starting April 22, 2022 in equal monthly amounts.
The option is subject to an early exercise provision and is immediately exercisable. Vesting is monthly over a 36-month period starting January 1, 2023.
Exhibit 24 - Power of Attorney
/s/ Jeff Woodley, Attorney-in-fact
2023-09-14
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints
each of Carlos Ramirez, Terren O'Connor, Michelle L. Hunt and Albert Gelin of
Cooley LLP, and Kenneth Song and Jeff Woodley of RayzeBio, Inc. (the "Company"),
signing individually, the undersigned's true and lawful attorney-in fact and
agent to:
(1) Prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the Securities and Exchange Commission (the "SEC"), a Form ID and
Forms 3, 4 and 5 (including amendments thereto and joint filing agreements in
connection therewith) in accordance with Section 16 of the Securities Exchange
Act of 1934, as amended (the "Exchange Act"), and the rules thereunder, in the
undersigned's capacity as an officer, director or beneficial owner of more than
10% of a registered class of securities of the Company;
(2) Do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute such Form ID and Forms 3,
4 or 5 (including amendments thereto and joint filing agreements in connection
therewith), and file such forms or amendments with the SEC and any stock
exchange, self-regulatory association or any similar authority; and
(3) Take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-facts discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-facts substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that each of the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, is not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the foregoing attorney-in-fact or (c) as to any attorney-in-fact
individually, until such attorney-in-fact is no longer employed by the Company
or employed by or a partner at Cooley LLP or another law firm representing the
Company, as applicable.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 1st day of September, 2023.
/s/ Angie You, Ph.D.